InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: unpathedhaunt post# 146815

Wednesday, 10/30/2013 1:39:57 PM

Wednesday, October 30, 2013 1:39:57 PM

Post# of 346200
Thanks for that post.

and the rest of the Scientific Advisors ... for LUNGevity -- happen to see David Carbone in there

Denise R. Aberle, MD
David Geffen School of Medicine at UCLA
Professor and Vice Chair of Research, Radiology

Nasser Altorki, MB, BCh
NewYork-Presbyterian/Weill Cornell Medical Center
Professor of Cardiothoracic Surgery
Chief, Division of Thoracic Surgery

Philip D. Bonomi, MD
Rush University Medical Center
Alice Pirie Wirtz Professor of Medical Oncology
Director, Division of Hematology-Oncology

David Carbone, MD, PhD
The Ohio State University
Professor, Division of Medical Oncology
Barbara J. Bonner Chair in Lung Cancer Research
Director of the Thoracic Oncology Center

Martin "Mac" Cheever, MD
Fred Hutchinson Cancer Research Center
Director, Cancer Immunotherapy Trials Network

Steven M. Dubinett, MD
David Geffen School of Medicine at UCLA
Chief, Division of Pulmonary and Critical Care Medicine
Senior Associate Dean for Translational Research
Associate Vice Chancellor for Research
Director, Clinical and Translational Science Institute (CTSI)

John V. Heymach, MD, PhD
The University of Texas MD Anderson Cancer Center
Professor and Chairman, Department of Thoracic/Head and Neck Medical Oncology
Division of Cancer Medicine

James Jett, MD
National Jewish Health
Professor of Medicine

Robert L. Keith, MD
University of Colorado, Denver
Professor of Medicine and Cancer Biology
Denver VAMC
Associate Chief of Staff - Research

J. Jack Lee, PhD, DDS
The University of Texas MD Anderson Cancer Center
Professor of Biostatistics
Kenedy Foundation Chair in Cancer Research

Scott Lippman, MD
University of California, San Diego
Director, Moores Cancer Center
Chugai Pharmaceutical Chair
Professor of Medicine

Pierre Massion, MD
Vanderbilt-Ingram Cancer Center
Professor of Medicine and Cancer Biology
Director, Thoracic Program

Charles Rudin, MD, PhD
Memorial Sloan-Kettering Cancer Center
Chief, Thoracic Oncology Service

Lawrence H. Schwartz, MD
Columbia University Medical Center
James Picker Professor and Chairman, Department of Radiology
NewYork Presbyterian Hospital/Columbia University Medical Center
Radiologist-in-Chief

Lecia V. Sequist, MD, MPH
Harvard Medical School
Associate Professor of Medicine
Massachusetts General Hospital Cancer Center - Center for Thoracic Cancer
Attending Oncologist

Steven J. Skates, PhD
Harvard Medical School and Massachusetts General Hospital
Associate Professor

Avrum Spira, MD, MSci
Boston University
Professor of Medicine, Pathology and Bioinformatics
Alexander Graham Bell Professor in Healthcare Entrepreneurship
Chief, Section of Computational Biomedicine

Margaret R. Spitz, MD, MPH
Baylor College of Medicine
Professor, Dan L. Duncan Cancer Center

http://events.lungevity.org/site/PageServer?pagename=v2_AboutUs_ScientificAdvisoryBoard
---------------------------------------------------------------

.... for those that didn't know... David Carbone is with Bristol Myers Squibb, maybe he is trying to save the deal... tell them (BMS) to open that vault all the way : ) - for confirmation you can see David Carbones name at the very end of this site-- names are highlighted ( no Dr. Robert Schwartz in there though : )

http://www.gotoper.com/conferences/ilc/meetings/14th-international-lung-cancer-congress

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News